Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Change in Accured Expenses (2016 - 2020)

Historic Change in Accured Expenses for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $120000.0.

  • Forte Biosciences' Change in Accured Expenses fell 2405.06% to $120000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.2 million, marking a year-over-year decrease of 127610.29%. This contributed to the annual value of $109000.0 for FY2024, which is 4139.78% down from last year.
  • According to the latest figures from Q4 2020, Forte Biosciences' Change in Accured Expenses is $120000.0, which was down 2405.06% from $33000.0 recorded in Q3 2020.
  • Over the past 5 years, Forte Biosciences' Change in Accured Expenses peaked at $3.1 million during Q4 2018, and registered a low of -$3.7 million during Q2 2020.
  • Over the past 5 years, Forte Biosciences' median Change in Accured Expenses value was $139000.0 (recorded in 2019), while the average stood at $284650.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 205222.93% in 2018, then plummeted by 84778.16% in 2019.
  • Over the past 5 years, Forte Biosciences' Change in Accured Expenses (Quarter) stood at $214000.0 in 2016, then plummeted by 173.36% to -$157000.0 in 2017, then skyrocketed by 2052.23% to $3.1 million in 2018, then crashed by 94.85% to $158000.0 in 2019, then decreased by 24.05% to $120000.0 in 2020.
  • Its last three reported values are $120000.0 in Q4 2020, $33000.0 for Q3 2020, and -$3.7 million during Q2 2020.